These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31262226)
1. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. Cai Q; Teeple A; Wu B; Muser E J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226 [No Abstract] [Full Text] [Related]
2. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. Feldman SR; Zhao Y; Shi L; Tran MH J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388 [TBL] [Abstract][Full Text] [Related]
3. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population. Lee S; Xie L; Wang Y; Vaidya N; Baser O J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606 [TBL] [Abstract][Full Text] [Related]
4. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Feldman SR; Zhao Y; Shi L; Tran MH; Lu J Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478 [TBL] [Abstract][Full Text] [Related]
5. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204 [TBL] [Abstract][Full Text] [Related]
6. Burden of chronic urticaria relative to psoriasis in five European countries. Balp MM; Khalil S; Tian H; Gabriel S; Vietri J; Zuberbier T J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):282-290. PubMed ID: 28898460 [TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. Han C; Lofland JH; Zhao N; Schenkel B J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505 [TBL] [Abstract][Full Text] [Related]
8. Economic Burden of Comorbidities in Patients with Psoriasis in the USA. Wu JJ; Suryavanshi M; Davidson D; Patel V; Jain A; Seigel L Dermatol Ther (Heidelb); 2023 Jan; 13(1):207-219. PubMed ID: 36402940 [TBL] [Abstract][Full Text] [Related]
9. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States. Pilon D; Teeple A; Zhdanava M; Ladouceur M; Ching Cheung H; Muser E; Lefebvre P J Med Econ; 2019 Feb; 22(2):196-203. PubMed ID: 30523738 [TBL] [Abstract][Full Text] [Related]
10. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder. Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634 [TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. Dalal AA; Shah M; Lunacsek O; Hanania NA COPD; 2011 Aug; 8(4):293-9. PubMed ID: 21827298 [TBL] [Abstract][Full Text] [Related]
12. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Hanna ML; Singer D; Valdecantos WC Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113 [TBL] [Abstract][Full Text] [Related]
13. The medical costs of migraine and comorbid anxiety and depression. Pesa J; Lage MJ Headache; 2004 Jun; 44(6):562-70. PubMed ID: 15186300 [TBL] [Abstract][Full Text] [Related]
14. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. Al Sawah S; Foster SA; Goldblum OM; Malatestinic WN; Zhu B; Shi N; Song X; Feldman SR J Med Econ; 2017 Sep; 20(9):982-990. PubMed ID: 28635342 [TBL] [Abstract][Full Text] [Related]
15. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035 [TBL] [Abstract][Full Text] [Related]
16. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887 [TBL] [Abstract][Full Text] [Related]
17. Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression? Pilon D; Sheehan JJ; Szukis H; Morrison L; Zhdanava M; Lefebvre P; Joshi K J Affect Disord; 2019 Aug; 255():50-59. PubMed ID: 31128505 [TBL] [Abstract][Full Text] [Related]
18. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States. Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144 [TBL] [Abstract][Full Text] [Related]
19. Burden of Herpes Zoster Among Patients with Psoriasis in the United States. Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Sendhil SR; Sundar M; Hagopian E; Stempniewicz N; Duh MS; Poston S Dermatol Ther (Heidelb); 2023 Nov; 13(11):2649-2668. PubMed ID: 37740149 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the economic burden of psoriasis in the United States. Vanderpuye-Orgle J; Zhao Y; Lu J; Shrestha A; Sexton A; Seabury S; Lebwohl M J Am Acad Dermatol; 2015 Jun; 72(6):961-7.e5. PubMed ID: 25882886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]